References
- Pedersen-Bjergaard J. Insights into leukemogenesis from therapy-related leukaemia. N Engl J Med 2005; 352: 1591–4
- de Gramont A, Vignoud J, Tournigand C, Louvet C, Andre T, Varette C, et al. Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer. Eur J Cancer 1997; 33: 214–9
- Caglar K, Varan A, Akyuz C, Selek U, Kutluk T, Yalcin B, et al. Second neoplasms in pediatric patients treated for cancer: A center's 30-year experience. J Ped Hematol Oncol 2006; 28: 374–8
- Crump M, Tu D, Shepherd L, Levine M, Bramwell V, Pritchard K. Risk of acute leukaemia following epirubicin-based adjuvant chemotherapy: A report from the National Cancer Institute of Canada Clinical trials group. JCO 2003; 21: 3066–71
- Ishizawa S, Slovak ML, Popplewell L, Bedell V, Wrede JE, Carter NH, et al. High frequency of pro-B acute lymphoblastic leukaemia in adults with secondary leukaemia with 11q23 abnormalities. Leukaemia 2003; 17: 1091–5
- Auxenfants E, Morel P, Lai JL, Sartiaux C, Detourmignies L, Bauters F, et al. Secondary acute lymphoblastic leukaemia with t (4;11): Report on two cases and review of the literature. Ann Hematol 1992; 65: 143–6
- Bigoni R, Cuneo A, Roberti MG, Moretti S, De Angeli C, Dabusti M, et al. Therapy-related adult acute lymphoblastic leukaemia with t(4;11)(q21; q23): MLL rearrangement, p53 mutation and multilineage involvement. Leukaemia 1999; 13: 704–7
- Merrouche, Y, Mugneret, F, Cahn, JY. Secondary acute promyelocytic leukaemia following irinotecan and oxaliplatin for advanced colon cancer. Ann Oncol 2006;17:1025–6. Epub 2005 Nov 17.
- Carneiro BA, Kaminer L, Eldibany M, Sreekantaiah C, Kaul K, Locker GY. Oxaliplatin-related acute myelogenous leukaemia. Oncologist 2006; 11: 261–2
- Rund D, Ben-Yehuda D. Therapy-related leukaemia and myelodysplasia: Evolving concepts of pathogenesis and treatment. Hematology 2004; 9: 179–87
- Takeyama K, Seto M, Uike N, Hamajima N, Ino T, Mikuni C, et al. Therapy-related leukaemia and myelodysplastic syndrome: A large-scale Japanese study of clinical and cytogenetic features as well as prognostic factors. Int J Hematol 2000; 71: 144–52